These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26048626)

  • 41. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
    Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
    Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
    Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
    Front Immunol; 2020; 11():576152. PubMed ID: 33162992
    [No Abstract]   [Full Text] [Related]  

  • 44. Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Kirresh A; Everitt A; Kon OM; DasGupta R; Pickering MC; Lachmann HJ
    Pract Neurol; 2016 Aug; 16(4):304-7. PubMed ID: 26965498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult-onset tumour necrosis factor receptor-associated periodic syndrome presenting with refractory chronic arthritis.
    Lopalco G; Rigante D; Vitale A; Galeazzi M; Iannone F; Cantarini L
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S171-2. PubMed ID: 25936627
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
    Rigante D; Lopalco G; Vitale A; Lucherini OM; De Clemente C; Caso F; Emmi G; Costa L; Silvestri E; Andreozzi L; Iannone F; Galeazzi M; Cantarini L
    Clin Rheumatol; 2014 Sep; 33(9):1197-207. PubMed ID: 24935411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
    Cudrici C; Deuitch N; Aksentijevich I
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subclinical TRAPS treated with canakinumab.
    Amatruda M; Carucci NS; Fede C; Conti G
    Reumatismo; 2021 Aug; 73(2):131-134. PubMed ID: 34342215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion.
    Rowczenio DM; Trojer H; Omoyinmi E; Aróstegui JI; Arakelov G; Mensa-Vilaro A; Baginska A; Silva Pilorz C; Wang G; Lane T; Brogan P; Hawkins PN; Lachmann HJ
    Arthritis Rheumatol; 2016 Aug; 68(8):2044-9. PubMed ID: 26992170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
    Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoinflammatory Diseases with Periodic Fevers.
    Sag E; Bilginer Y; Ozen S
    Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptoms related to tumor necrosis factor receptor 1-associated periodic syndrome, multiple sclerosis, and severe rheumatoid arthritis in patients carrying the TNF receptor superfamily 1A D12E/p.Asp41Glu mutation.
    Havla J; Lohse P; Gerdes LA; Hohlfeld R; Kümpfel T
    J Rheumatol; 2013 Mar; 40(3):261-4. PubMed ID: 23322460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.
    Cantarini L; Lucherini OM; Galeazzi M; Fanti F; Simonini G; Baldari CT; Laghi Pasini F; De Martino M; Cimaz R
    Clin Exp Rheumatol; 2009; 27(5):890-1. PubMed ID: 19917181
    [No Abstract]   [Full Text] [Related]  

  • 55. Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study.
    Gattorno M; Obici L; Cattalini M; Tormey V; Abrams K; Davis N; Speziale A; Bhansali SG; Martini A; Lachmann HJ
    Ann Rheum Dis; 2017 Jan; 76(1):173-178. PubMed ID: 27269295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TNFRSF1A Gene Causing Tumor Necrosis Factor Receptor-associated Periodic Syndrome in 2 Siblings Displaying Variable Disease Severity and Discordant Heterozygosity for an MEFV E148Q Variant.
    Abdwani R; Abdalla E; Al Abrawi S; Al-Thihli K
    J Rheumatol; 2015 Aug; 42(8):1534-5. PubMed ID: 26233954
    [No Abstract]   [Full Text] [Related]  

  • 57. Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3 pivotal study (24-week results).
    Imagawa T; Nishikomori R; Takada H; Takeshita S; Patel N; Kim D; Lheritier K; Heike T; Hara T; Yokota S
    Clin Exp Rheumatol; 2013; 31(2):302-9. PubMed ID: 23380020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Trap" the diagnosis: a man with recurrent episodes of febrile peritonitis, not just familial Mediterranean fever.
    Arad U; Niv E; Caspi D; Elkayam O
    Isr Med Assoc J; 2012 Apr; 14(4):229-31. PubMed ID: 22675839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria.
    Solakov PT
    Folia Med (Plovdiv); 2016 Sep; 58(3):211-214. PubMed ID: 27760004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
    Vinit C; Georgin-Lavialle S; Theodoropoulou A; Barbier C; Belot A; Mejbri M; Pillet P; Pachlopnik J; Poignant S; Rebelle C; Woerner A; Koné-Paut I; Hentgen V
    Front Immunol; 2021; 12():744780. PubMed ID: 34858402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.